Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03327584 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis
A NA study of Effusion Joint, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03327584 is a NA study of Effusion Joint that has completed, run by Temple University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03327584, a NA study of Effusion Joint, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Arthrocentesis is the removal of synovial fluid for analysis of pathologic processes. Small \& medium joint arthrocentesis will be defined as the following joints: elbow, wrist, finger, ankle and toe. Ultrasound (US) and landmark (LM) small \& medium joint arthrocentesis are both performed within the clinical setting. Both techniques are considered standard of care. Selection of which technique to use is dependent upon the physician's preference. There is currently limited data comparing the two methods. The investigators hope to determine if one modality is more effective in terms of success rate, number of attempts, and time to complete the procedure.
Conditions Studied
Interventions
- PROCEDURE Arthrocentesis
Study Locations (1)
Pennsylvania
- Lewis Katz School of Medicine at Temple University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03327584
The ClinicalTrials.gov registry entry for NCT03327584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Effusion Joint appearing as the primary indexed condition, and to 1 intervention - of which Arthrocentesis is the first listed.
NCT03327584 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03327584 about?
NCT03327584 is a clinical study titled "Ultrasound Guided Versus Landmark Guided Small & Medium Joint Arthrocentesis". Arthrocentesis is the removal of synovial fluid for analysis of pathologic processes. Small \& medium joint arthrocentesis will be defined as the following joints: elbow, wrist, finger, ankle and toe. Ultrasound (US) and landmark (LM) small \& medium joint arthrocentesis are both performed within th...
What is the current status of trial NCT03327584?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-01-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03327584 study?
This clinical trial studies the following conditions: Effusion Joint.
What interventions are being tested in trial NCT03327584?
The interventions under investigation include: Arthrocentesis (PROCEDURE).
Who is sponsoring clinical trial NCT03327584?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03327584 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.